ISTA Pharmaceuticals, Inc. to Present at 2009 BIOCOM Investor Conference
IRVINE, Calif., Oct. 20 /PRNewswire-FirstCall/ -- ISTA Pharmaceuticals, Inc. , today announced it will present at the 2009 BIOCOM Investor Conference at 11:30 a.m. Pacific Time on October 27, 2009, at the Hyatt Regency La Jolla in San Diego, California.
ISTA's Chief Financial Officer, Lauren Silvernail, will provide an update on the Company's commercial and clinical progress. To access the live audio broadcast, or the subsequent archived recording, log onto http://www.istavision.com. Please connect to the website several minutes prior to the start of the presentation to ensure adequate time for any software download that may be necessary.
About ISTA Pharmaceuticals
ISTA Pharmaceuticals is the fourth largest branded ophthalmic pharmaceutical business in the U.S. ISTA's four marketed products plus its product candidates include therapies for inflammation, ocular pain, glaucoma, allergy, and dry eye. The Company is developing a strong product pipeline to fuel future growth and market share, thereby continuing its growth to become the leading niche ophthalmic pharmaceutical company in the U.S. For additional information regarding ISTA, please visit ISTA Pharmaceuticals' website at http://www.istavision.com.
SOURCE ISTA Pharmaceuticals, Inc.
CONTACT: Vince Anido, +1-949-788-5311, firstname.lastname@example.org, or Lauren
Silvernail, +1-949-788-5302, email@example.com, both of ISTA
Pharmaceuticals; or Media, Justin Jackson, firstname.lastname@example.org; or
Investors, Juliane Snowden, email@example.com, both of Burns McClellan,
+1-212-213-0006, for ISTA Pharmaceuticals
Web site: http://www.istavision.com/